casuistry for glutathione therapy:
increase of reduced glutathione (GSH) with GlutaCell
introduction and overview
glutathione, a sulfur-containing tripeptide, is in its reduced form (GSH) for almost all self-healing and protection mechanisms in the organism responsible.
reduced glutathione levels can be observed in almost all chronic diseases. As a result, basic, necessary for healing (immune) functions and can not proceed adequately.
The increase in glutathione levels has proven to be gentle, highly effective Basistheraphie, especially for AIDS, cancer, rheumatism, viral infections and the recent increases observed complex or multi-system diseases such as chronic disease or chronic fatigue syndrome (CFS).
therapeutic approach
As can be achieved by glutathione in capsules according to the current study situation, no clinically relevant effects and glutathione infusions have to be imported in the absence German approval from Italy, was elected a nutritional medical approach from German research.
The drug (GlutaCell) combines the central part of glutathione, the sulfur-containing amino acid cysteine, vitamin C and a special treatment of secondary plant compounds (polyphenols). This combination of active ingredients (GSH-intra) was developed specifically for the promotion of glutathione formation in the body cells. to provide
methods
The combined approach, the organism with the central glutathione-component cysteine, while targeted to promote glutathione formation within the cells was by the manufacturer as part of the observation GSH intra investigated.
The participating Patient (female, born 1969) with suspicion of the existence of chronic Lyme disease for 14 days GlutaCell received a capsule of the nutrient combination.
Before and after taking their content of reduced glutathione within the main immune cells
was examined in lymphocytes, monocytes and natural killer cells (NK cells).
The determination of intracellular glutathione levels was carried out by the Institute of Medical Diagnostics in Berlin (www.imd-berlin.de). Initial and final findings were released by Dr. Volker von Baehr.
results
The patient was an increase of reduced glutathione in the cells by more than 400% was observed. All values were decreased at the first examination were, in the final examination in the high normal range.
total, following increases are observed:
(values from the author)
‣ lymphocytes: from 111 to 791 mfi
‣ monocytes: from 174 to 673 mfi
‣ NK cells: from Additional 261 to 1084 mfi
information: www.phytovital.com
0 comments:
Post a Comment